Product Information
CICLOPIROX 8% SOLUTION is a generic product labeled by Acella Pharmaceuticals, LLC, priced at $1.1541 per ML under NDC 42192071506. Its NADAC has been published 353 times since Jan 1, 2020.
FDA first approved this application on Sep 18, 2007. Its Orange Book therapeutic-equivalence code is AT.
The High Outlier badge above means this manufacturer's average price in the Ciclopirox market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
80 mg/mL
Manufacturer
Acella Pharmaceuticals, LLCNDC
42192071506
Classification
Generic
Dosage Form
SOLUTION
Route
TOPICAL
Effective Date
9/23/2026
Active Ingredients
CICLOPIROXApproval Type
Generic (ANDA)
FDA Application
ANDA078172FDA Approved
9/18/2007
TE Code
AT
On Market Since
11/4/2019
Pharmacological Classes
Price Statistics
The NADAC for CICLOPIROX 8% SOLUTION has been published 353 times since Jan 1, 2020, and over the history we have for it it has declined 44.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.1541 per ML |
|---|---|
| All-time high | $2.2522 (Aug 11, 2021) |
| All-time low | $1.1541 (Sep 23, 2026) |
| 52-week high | $1.4170 |
| 52-week low | $1.1541 |
| Median price | $1.8015 |
| Average price | $1.7325 |
| Largest weekly change | -27.3% (Nov 20, 2024) |
| Weeks tracked | 353 |
| Tracking since | Jan 1, 2020 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Acella Pharmaceuticals, LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Ciclopirox market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CICLOPIROX 8% SOLUTION?
The current National Average Drug Acquisition Cost (NADAC) for CICLOPIROX 8% SOLUTION, manufactured by Acella Pharmaceuticals, LLC, is $1.1541 per ML (NDC 42192071506), effective Sep 30, 2026.
How has the price of CICLOPIROX 8% SOLUTION changed over time?
Over the history we have for it, the NADAC for CICLOPIROX 8% SOLUTION has declined 44.8%. It has been tracked across 353 weekly CMS publications since Jan 1, 2020.
What are the highest and lowest recorded NADAC prices for CICLOPIROX 8% SOLUTION?
Since Jan 1, 2020, the NADAC for CICLOPIROX 8% SOLUTION has ranged from a low of $1.1541 (Sep 23, 2026) to a high of $2.2522 (Aug 11, 2021), with a median of $1.8015 per ML.
Are there cheaper alternatives to CICLOPIROX 8% SOLUTION?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as CICLOPIROX 8% SOLUTION in a comparable dosage form, but none are currently priced below it.
Who manufactures CICLOPIROX 8% SOLUTION?
CICLOPIROX 8% SOLUTION (NDC 42192071506) is labeled by Acella Pharmaceuticals, LLC, and CMS classifies it as a generic product.